RNA therapeutics

Pharmacy

Queen's University Belfast

School of Pharmacy

Location
Belfast, United Kingdom
Funding
See university guidance
Application deadline
See university guidance

About the project

My research focuses on developing innovative RNA-based nanomedicines for cancer immunotherapy, with a particular emphasis on glioblastoma. I specialise in engineering non-viral delivery systems, including lipid- and polymer-based nanoparticles, for targeted delivery of therapeutic RNA. My work integrates nanotechnology, RNA therapeutics, and immune engineering to modulate the tumour microenvironment and enable in vivo generation of CAR-T cells, aiming to overcome current limitations in brain cancer treatment and advance next-generation precision immunotherapies.

  • Dr Flavia Sousa: School of Pharmacy

Contact info

  • View Academic Profile
  • f.sousa@qub.ac.uk
  • @flaviasousasci

Research Interests

Open to PhD applications in the fields of:

Make a PhD enquiry

  • RNA therapeutics
  • Drug delivery
  • Cancer immunotherapy
  • Biomaterials
  • Non-viral gene delivery
  • Immune engineering
  • CAR-T cell therapies

Public outreach & key achievements

  • 2026 Jury President of 3th edition Dr. Mário Fonseca Award – Raise the award to 30k
  • 2025 Jury President of 2nd edition Dr. Mário Fonseca Award – Raise the award to 30k
  • 2025 UNESCO Women in Science initiative – 10 year anniversary
  • 2024 Founder and Jury President, Dr. Mário Fonseca Award: Established a 20k award for early-career researchers, sponsored by the City Wall of Lousada, Portugal and SOMA company. Responsible for drafting the award regulations and leading the evaluation process as jury president.
  • 2024 Podcast in L Fração: Interview with Flavia Sousa about cancer immunotherapy
  • 2023 PhD career stories: Interview with Flavia Sousa on Academic Mentorship and Transferable Skills
  • 2023 A researcher in my class, Collège Saint-Michel, Fribourg
  • 2023 Outreach with CSL Vifor about my research work
  • 2023 TEDx talk about: How can we stop scientists from leaving academic life
  • 2023 Equal opportunities – Women in Science
  • 2023 A researcher in my class, Collège de Gambach, Fribourg
  • 2023 Interview from Portuguese newspaper
  • 2022 UNIFR news
  • 2021 Debate with Prof. Dr. Sobrinho Simões, president of IPATIMUP

Research students

PhD Title | Next Generation of polymeric nanovaccine for brain cancer immunotherapy

Name | Fatima Hameedat

Years of study | 2023 - 2027

Country | Jordan

Discover More

  • Faculty of Medicine, Health & Life Sciences
  • School of Pharmacy
  • Medical Biology Centre
  • www.flaviasousasci.com

Research areas

RNA therapeuticsnon-viral gene deliverydrug deliveryImmunotherapyBiomaterialsengineeringEngineeringCancer

Related PhD opportunities